Venture Leaders Biotech 2022: 10 innovative startups will advance their global growth in Boston – Healiva is among the 10 startups chosen

27 July 2022

Comunicato stampa – Piero Poli nuovo Presidente di FIT

15 June 2022

New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

7 June 2022

Conferenza stampa Farma Industria Ticino – 30 maggio 2022

3 June 2022

Healiva® acquisisce da Smith+Nephew due asset di terapia cellulare per la guarigione delle ferite

2 June 2022

Helsinn Establishes New R&D Hub in the U.S. to Support its Global Fully Integrated Targeted Therapy (FITT) Strategy

30 May 2022

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer

20 May 2022

Helsinn to present data at upcoming AMMF’s 2022 European Cholangiocarcinoma Conference

17 May 2022

Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi®

17 May 2022

United States Ambassador Scott Miller meets the Chairman of Farma Industria Ticino Association

12 May 2022